Form 4: SI-BONE CFO Sells Shares Under 10b5-1 Plan

SI-BONE, Inc.'s Chief Financial Officer, Anshul Maheshwari, reported the sale of 2,601 shares of common stock under a pre-arranged 10b5-1 trading plan.

Summary

• Anshul Maheshwari, Chief Financial Officer of SI-BONE, Inc. (SIBN), sold 2,601 shares of the company's common stock.
• The transaction is reported to have occurred on November 11, 2025.
• The shares were sold at a weighted-average price of $18.3333, with individual sales ranging from $17.00 to $19.00.
• The sale was executed pursuant to a Rule 10b5-1 trading plan established on December 13, 2024.
• Following this transaction, Anshul Maheshwari beneficially owns 208,533 shares, which includes 150,203 shares issuable upon the settlement of restricted stock units.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction executed under a pre-arranged 10b5-1 plan. Such sales are typically for personal financial planning and diversification, not necessarily indicative of a change in company fundamentals. The transaction size is relatively small compared to the CFO's total beneficial ownership.

Positives

• The sale was conducted under a pre-arranged 10b5-1 trading plan, indicating a planned transaction for personal financial management rather than an immediate reaction to market conditions or new information.

Negatives

• A Chief Financial Officer selling shares, even under a 10b5-1 plan, could be perceived negatively by some investors, though the amount is relatively small compared to total beneficial ownership.

Future Outlook

N/A

Industry Context

N/A

Stakeholder Impact

• Shareholders: May view the CFO's sale with slight caution, although the execution under a 10b5-1 plan mitigates concerns about opportunistic selling. The overall impact on shareholder sentiment is likely minimal given the transaction's nature and size.

Key Dates

Recommendation

This Form 4 details a pre-scheduled insider stock sale by the CFO under a 10b5-1 plan. These transactions are generally for personal financial management and diversification, not a signal of a shift in the company's operational or financial outlook. The sale amount is not substantial enough to warrant a change in investment strategy based solely on this filing. Investors should maintain their current position and continue to monitor the company's core business performance.

Keywords

SI-BONE, SIBN, Form 4, Insider Trading, Stock Sale, CFO, Anshul Maheshwari, 10b5-1 Plan, Equity Transaction